MARC A TACK
Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease KINGSTON, NY NPI 1376582015
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease NY Shionogi Inc All categories
General Payments — all program years on this page
$50,075.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 668
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,427.94 across 79 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,962.50 | 1 |
| Food and Beverage | $1,453.12 | 76 |
| Education | $12.32 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Shionogi Inc | $2,963.97 | 2 |
| Gilead Sciences, Inc. | $313.79 | 18 |
| ABBVIE INC. | $195.78 | 9 |
| ViiV Healthcare Company | $192.71 | 10 |
| Merck Sharp & Dohme Corporation | $184.70 | 11 |
| Amgen Inc. | $123.05 | 7 |
| PFIZER INC. | $88.92 | 5 |
| Insmed, Inc. | $75.29 | 3 |
| SANOFI-AVENTIS U.S. LLC | $54.98 | 2 |
| Paratek Pharmaceuticals, Inc. | $54.77 | 3 |
| Otsuka America Pharmaceutical, Inc. | $46.21 | 2 |
| DEXCOM, INC. | $24.14 | 1 |
| Inspire Medical Systems, Inc. | $22.76 | 1 |
| EMD Serono, Inc. | $18.30 | 1 |
| GlaxoSmithKline, LLC. | $17.75 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.53 | 1 |
| Lilly USA, LLC | $17.10 | 1 |
| Novo Nordisk AS | $16.19 | 1 |
By program year
Records — PY2024 (79)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.